Growth Of The Biopharmaceutical Sector Driving Demand For In DNA And RNA Synthesis Is Supporting Development Across The Phosphoramidite Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Phosphoramidite Market From 2026 To 2030?

The phosphoramidite market size has demonstrated robust growth in recent years. It is projected to expand from $1.07 billion in 2025 to $1.15 billion in 2026, recording a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be attributed to various factors, including the increasing number of DNA sequencing activities, an rise in academic research funding, wider adoption of synthetic nucleic acids, advancements in solid-phase synthesis techniques, and a growing demand for molecular diagnostics.

The phosphoramidite market size is anticipated to undergo significant expansion over the forthcoming years. It is projected to reach $1.5 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This expansion during the forecast period can be attributed to the broadening application of RNA-based therapeutics, advancements in gene editing technologies, augmented pharmaceutical R&D investment, a rising need for custom oligonucleotides, and the scaling of automated synthesis platforms. Prominent trends expected in this period include an increasing demand for oligonucleotide synthesis materials, the growing prevalence of gene therapy and RNA therapeutics, their expanding utility in diagnostic and research applications, the increasing adoption of automated solid-phase synthesis, and a heightened emphasis on high-purity chemical inputs.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

Which Strategic Drivers Are Supporting The Phosphoramidite Market Development?

The expanding biopharmaceutical sector is projected to fuel the growth of the phosphoramidite market in the upcoming period. This sector broadly covers the industry involved in the research, development, production, and commercialization of medical products derived from biological sources, including vaccines, gene therapies, monoclonal antibodies, and recombinant proteins. The expansion of the biopharmaceutical sector is primarily attributed to advancements in biotechnology, the increasing global prevalence of chronic diseases, and escalating investments in research and development. Innovations in biotechnology, such as gene editing and monoclonal antibody therapies, have facilitated the development of more effective and precisely targeted treatments. For instance, in October 2025, the Office for National statistics, a UK-based government department, reported that in 2024, the UK life sciences industry comprised 6,170 businesses operating across 7,320 sites, employing 359,600 people and generating $191 billion (£146.9 billion) in turnover. Among these, medical technology stood out as the largest subsector by both company count and workforce, representing 60% of all companies and 55% of total employment. Therefore, the significant growth of the biopharmaceutical sector is a key factor driving the phosphoramidite market’s expansion.

What Are The Core Segment Classifications In The Phosphoramidite Market?

The phosphoramidite market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Phosphoramidites, Ribonucleic Acid (RNA) Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites, Other Types

2) By Synthesis Method: H-Phosphonate Method, Phosphoramidite Method, Trivalent Phosphorus Compounds Method

3) By Application: Gene Synthesis, Deoxyribonucleic Acid (DNA) Sequencing, Deoxyribonucleic Acid (DNA) Amplification

4) By End-User: Academic Research, Pharmaceutical Industry, Biotechnology Industry

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Phosphoramidites: Standard DNA Phosphoramidites, Degenerate DNA Phosphoramidites, Methylated DNA Phosphoramidites, Backbone-Modified DNA Phosphoramidites

2) By Ribonucleic Acid (RNA) Phosphoramidites: Standard RNA Phosphoramidites, 2′-O-Methyl RNA Phosphoramidites, 2′-Fluoro RNA Phosphoramidites, 2′-O-TBDMS Protected RNA Phosphoramidites

3) By Labeled Phosphoramidites: Fluorescent-Labeled Phosphoramidites, Biotin-Labeled Phosphoramidites, Digoxigenin-Labeled Phosphoramidites, Radioisotope-Labeled Phosphoramidites

4) By Modifier Phosphoramidites: Amine-Modified Phosphoramidites, Thiol-Modified Phosphoramidites, Spacer Phosphoramidites, Azide-Modified Phosphoramidites

5) By Other Types: Chimeric Phosphoramidites, Phosphorothioate Phosphoramidites, PEGylated Phosphoramidites, Photo-Cleavable Phosphoramidites

Which Trends Are Guiding The Development Of The Phosphoramidite Market?

Major companies in the phosphoramidite market are prioritizing the development of advanced DNA synthesis methods, such as utilizing convertible-preferred stock financing rounds to enhance the adoption and advancement of Gibson SOLA technology for quick DNA and mRNA synthesis. Convertible-preferred stock financing represents a capital-raising strategy where a company issues preferred shares that possess the option to be converted into a predetermined quantity of common shares later. For instance, in March 2025, Telesis Bio Inc., a US-based biotechnology company, announced it had secured up to $21 million in new funding to expedite the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA, with backing from several strategic investors. This funding is allocated to expand the company’s fully enzymatic DNA synthesis technology, grow its research and development and manufacturing capabilities, and broaden access to rapid, customizable long-DNA production. The company employs a proprietary enzymatic method that enables the fast and precise synthesis of long DNA sequences, addressing existing limitations associated with traditional phosphoramidite-based approaches.

Which Companies Are Engaged In The Phosphoramidite Market Environment?

Major companies operating in the phosphoramidite market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., emp BIOTECH GmbH

Access The Complete Phosphoramidite Market Report:

https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report

Which Regional Market Leads The Phosphoramidite Market?

North America was the largest region in the phosphoramidite market in 2025. Europe is expected to be the fastest-growing region during the forecast period. The regions covered in the phosphoramidite market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Phosphoramidite Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=22096&type=smp

Browse Through More Reports Similar to the Global Phosphoramidite Market 2026, By The Business Research Company

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Phosphoric Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphoric-acid-global-market-report

Phosphonates Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosphonates-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795